Physiologic Reserve Biomarkers in Emergency Care

Abstract

Physiologic reserve represents the capacity of organ systems to withstand stress and maintain homeostasis in the face of acute illness or injury. In emergency care, rapid assessment of physiologic reserve can be pivotal for risk stratification and clinical decision-making, especially in elderly or critically ill patients. Recent advances in biomarker research have enabled the identification and clinical application of specific biomarkers that reflect the physiologic reserve across cardiovascular, renal, hepatic, and immune systems. This review synthesizes current evidence on the most promising physiologic reserve biomarkers in emergency settings, their mechanisms, clinical utility, and the implications for acute patient management.

Introduction

Emergency care often involves patients with complex physiological challenges, where the ability to rapidly gauge a patient's physiologic reserve is critical for triage, intervention, and prognostication. Traditional vital signs and clinical assessments can be insufficient to capture subclinical depletion of reserve, particularly in populations with atypical presentations such as geriatric or immunocompromised patients. The integration of novel biomarkers that objectively quantify physiologic reserve can transform acute care delivery by improving early detection of decompensation and guiding personalized management strategies.

Epidemiology / Disease Burden

The burden of acute illness requiring emergency care is increasing globally, particularly among aging populations and those with multiple comorbidities. Patients with diminished physiologic reserve are at heightened risk for adverse outcomes such as shock, multi-organ dysfunction, prolonged hospitalization, and mortality. Studies indicate that up to 30% of older adults presenting to emergency departments (EDs) exhibit frailty or low physiologic reserve, correlating with significantly higher morbidity and resource utilization. Early identification of patients with low reserve remains a clinical challenge, highlighting the need for reliable, evidence-based biomarkers.

Pathophysiology

Physiologic reserve reflects the cumulative capacity of organ systems, including the cardiovascular, respiratory, renal, hepatic, and immune systems, to adapt to acute stressors. Mechanistically, reserve is shaped by baseline organ function, cellular and molecular resilience, and the ability to mount compensatory responses. Biomarkers of physiologic reserve typically capture aspects of subclinical organ dysfunction, impaired stress response, or altered metabolic homeostasis. For example, elevated natriuretic peptides may indicate reduced cardiac reserve, while increased lactate reflects impaired perfusion and metabolic stress. Inflammatory mediators such as interleukin-6 signal immune exhaustion and diminished adaptive capacity, particularly in sepsis or trauma.

Risk Factors

Key risk factors for reduced physiologic reserve include advanced age, frailty, chronic comorbidities (e.g., heart failure, chronic kidney disease, chronic liver disease), malnutrition, and prior episodes of acute organ dysfunction. Polypharmacy, immobility, and cognitive impairment further contribute to the depletion of reserve. In the ED, patients presenting with nonspecific symptoms, altered mentation, or unexplained hemodynamic instability should be considered at risk for low physiologic reserve, warranting prompt biomarker-based assessment.

Clinical Features

Clinically, diminished physiologic reserve may manifest as a blunted or delayed response to acute stress, atypical or subtle presentations of sepsis, shock, or acute decompensation, and a rapid progression from minor illness to critical deterioration. Early clinical signs are often nonspecific, underscoring the value of objective biomarkers. In elderly patients, common features include reduced mobility, unexplained falls, delirium, and functional decline preceding acute events.

Diagnosis

The diagnostic approach to physiologic reserve in emergency care incorporates both clinical assessment tools and laboratory biomarkers. Key biomarkers with proven or emerging clinical utility include B-type natriuretic peptide (BNP) and N-terminal proBNP (NT-proBNP) for cardiac reserve, serum lactate for circulatory/metabolic reserve, creatinine and cystatin C for renal reserve, and albumin or prealbumin for nutritional and hepatic reserve. Inflammatory markers such as C-reactive protein (CRP) and interleukin-6 (IL-6) are associated with immune reserve. Multimarker panels and scoring systems, such as the Sequential Organ Failure Assessment (SOFA) score, increasingly integrate physiologic reserve biomarkers to enhance risk stratification.

Treatment & Management

Management strategies in the ED for patients with reduced physiologic reserve focus on early identification, risk stratification, and tailored interventions. Biomarker-guided protocols can inform decisions regarding the need for intensive monitoring, aggressive resuscitation, early specialist involvement, and admission to higher levels of care. For example, elevated lactate or BNP may prompt expedited hemodynamic management, while evidence of immune exhaustion may influence antibiotic and sepsis bundle implementation. Ongoing reassessment using dynamic biomarker trends is crucial for monitoring response and adjusting therapy.

Recent Advances / Emerging Therapies

Recent research advancements have expanded the repertoire of physiologic reserve biomarkers, leveraging omics technologies, machine learning, and high-throughput assays. Novel biomarkers such as growth differentiation factor-15 (GDF-15), soluble urokinase plasminogen activator receptor (suPAR), and cell-free DNA are under investigation for their ability to capture multi-system reserve and predict adverse outcomes in acute care. Integration of biomarker data with electronic health records and artificial intelligence-driven decision support tools is also emerging, offering potential for real-time, precision risk assessment in the ED.

Guideline Recommendations

Contemporary emergency medicine guidelines increasingly endorse the use of objective biomarkers for risk stratification and early detection of critical illness. The Surviving Sepsis Campaign recommends serial lactate measurement for prognostication and monitoring response to therapy. Heart failure guidelines advocate for BNP and NT-proBNP assessment in acute dyspnea. Geriatric emergency guidelines recognize the role of frailty and reserve assessment, emphasizing multimodal approaches including biomarkers to guide disposition and resource allocation. However, standardized protocols for the comprehensive use of physiologic reserve biomarkers in emergency care continue to evolve.

Conclusion

Physiologic reserve biomarkers represent a crucial advancement in emergency care, enabling rapid, objective, and clinically meaningful assessment of patient risk and resilience. Their integration into ED protocols enhances early recognition of vulnerable patients, supports evidence-based management decisions, and holds promise for improving outcomes in acutely ill populations. Continued research and guideline development are needed to optimize biomarker selection, implementation, and interpretation for diverse emergency care scenarios.